RCMI Investigators

  1. Jiménez J, Rivera D, Benítez P, Tarrats H, Ramos A. Integrating Mental Health Services into a General Hospital in Puerto Rico. J Clin Psychol Med Settings. Mar 31, 2013. PMID: 23543328; PMCID: NA. Impact Factor (as of 2011): 1.488.†  Top
  2. Sepulveda-Orengo MT, Lopez AV, Soler-Cedeño O, Porter JT. Fear Extinction Induces mGluR5-Mediated Synaptic and Intrinsic Plasticity in Infralimbic Neurons. J Neurosci. Apr 24, 2013;33(17):7184-7193. doi: 10.1523/JNEUROSCI.5198-12.2013. PMID: 23616528; PMCID: NA. Impact Factor (as of 2011): 7.178.*  Top
  3. Cuevas M, Flores I, Thompson KJ, Ramos-Ortolaza DL, Torres-Reveron A, Appleyard CB. Stress Exacerbates Endometriosis Manifestations and Inflammatory Parameters in an Animal Model. Reprod Sci. Aug 2012;19(8):851-62. doi: 10.1177/1933719112438443. Epub 2012 Apr 23. PMID: 22527982; PMCID: NA. Impact Factor (as of 2010): 2.586.*  Top
  4. Martinez KG, Castro-Couch M, Franco-Chaves JA, Ojeda-Arce B, Segura G, Milad MR, Quirk GJ. Correlations between psychological tests and physiological responses during fear conditioning and renewal. Biol Mood Anxiety Disord. Sep 17, 2012;2(1):16. PMID: 22985550; PMCID: PMC3511243. Impact Factor: NA.  Top
  5. Castro-Couch M, Irani F, Houshyarnejad A, Norman M, Peery S. Training Disparities in neuropsychology: Results of the National Academy of Neuropsychology (NAN) Culture and Diversity Committee Survey. [Abstract] Arch Clin Neuropsychol. Sep 2012;27(6):576-685. PMID: 22869605. PMCID: NA. Impact Factor (as of 2011): 2.178.  Top
  6. Matta J, Echenique M, Negron E, Morales L, Vargas W, Gaetan Sánchez F, Lizardi Ramírez E, Torres A, Rosado Ortiz J, Bolaños G, Cruz González J, Laboy J, Barnes R, Medina Santiago S, Romero A, Martinez R, Dutil J, Suarez E, Alvarez-Garriga C, Bayona M. The association of DNA Repair with breast cancer risk in women. A comparative observational study. BMC Cancer. Oct 22, 2012;12:490. doi: 10.1186/1471-2407-12-490. PMID: 23088658; PMCID: PMC3572436. Impact Factor (as of 2011): 3.010.*†  Top
  7. Dutil J (as part of the 1000 Genomes Project Consortium), Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. An integrated map of genetic variation from 1,092 human genomes. Nature. Nov 1, 2012;491(7422):56-65. doi: 10.1038/nature11632. PMID: 23128226; PMCID: PMC3498066. Impact Factor (as of 2011): 36.101.  Top
  8. Dutil J, Colon-Colon JL, Matta JL, Sutphen R, Echenique M. Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico. Cancer Genet. May 2012;205(5):242-248. PMID: 22682623; PMCID: NA. Impact Factor (as of 2010): 1.551.  Top
  9. Avena S, Via M, Ziv E, Pérez-Stable EJ, Gignoux CR, Dejean C, Huntsman S, Torres-Mejía G, Dutil J, Matta JL, Beckman K, Burchard EG, Parolin ML, Goicoechea A, Acreche N, Boquet M, Ríos Part Mdel C, Fernández V, Rey J, Stern MC, Carnese RF, Fejerman L. Heterogeneity in Genetic Admixture across Different Regions of Argentina. PLoS One. 2012;7(4):e34695. doi: 10.1371/journal.pone.0034695. Epub 2012 Apr 10. PMID: 22506044; PMCID: PMC3323559. Impact Factor (as of 2009): 4.351.  Top
  10. Gwede CK, Castro E, Brandon TH, McIntyre J, Meade CD, Munoz-Antonia T, Simmons VN, Vadaparampil ST, Jimenez J, Quinn GP. Developing strategies for reducing cancer disparities via cross-institutional collaboration: outreach efforts for the partnership between the Ponce School of Medicine and the Moffitt Cancer Center. Health Promot Pract. Nov 2012;13(6):807-815. doi: 10.1177/1524839911404227. Epub 2011 Dec 12. PMID: 22167362; PMCID: NA. Impact Factor: NA.  Top
  11. Chompre G, Cruz E, Maldonado L, Rivera-Amill V, Porter JT, Noel RJ Jr. Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory. Neurobiol Dis. Aug 25, 2012;49C:128-136. doi: 10.1016/j.nbd.2012.08.007. PMID: 22926191; PMCID: 3530662. Impact Factor (as of 2011): 5.4033.*
  12. Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ Jr, Kaplan MH, Markovitz DM. Expression of Human Endogenous Retrovirus Type-K (HML-2) is activated by the Tat protein of HIV-1. J Virol. Aug 2012;86(15):7790-805. doi: 10.1128/JVI.07215-11. Epub 2012 May 16. PMID: 22593154; PMCID: PMC3421662. Impact Factor (as of 2010): 5.189.  Top
  13. Norman L, Williams BS, Rosenberg R, Alvarez Garriga C, Cintron L, Malow RM. “Bringing Testing to the People”: A Discussion of an HIV-Testing Outreach Project Targeting Impoverished Women. In: Sobhie Diaz R, ed. HIV Testing. Rijeka, Croatia: InTech; 2012. PMID: NA; PMCID: NA. Impact Factor: NA.  Top
  14. Santini E, Sepulveda-Orengo M, Porter JT. Muscarinic Receptors Modulate the Intrinsic Excitability of Infralimbic Neurons and Consolidation of Fear Extinction. Neuropsychopharmacology. Aug 2012;37(9):2047-2056. doi: 10.1038/npp.2012.52. Epub 2012 Apr 18. PMID: 22510723; PMCID: PMC3398732. Impact Factor (as of 2010): 6.685.*  Top
  15. Perez KJ, Martínez FP, Cosme-Cruz R, Perez-Crespo NM, Tang Q. A Short Cis-Acting Motif In The M112--113 Promoter Region Is Essential For IE3 To Activate M112-113 Gene Expression And Is Important For Murine Cytomegalovirus Replication. J Virol. Dec 19, 2012. PMID: 23255797; PMCID: PMC3571397. Impact Factor (as of 2010): 5.402.*  Top
  16. Rivera-Molina YA, Rojas BR, Tang Q. Nuclear domain 10-associated proteins recognize and segregate intranuclear DNA/Protein complexes to negate gene expression. Sep 28, 2012;9(1):222. PMID: 23021128; PMCID PMC3571397. Impact Factor (as of 2010): 2.34.*†  Top
  17. Martinez FP, Tang Q. The leucine zipper domain is required for the Kaposi Sarcoma-associated herpesvirus (KSHV) K-bZIP protein to interact with histone deacetylase and is important for KSHV replication. J Biol Chem. Mar 13, 2012. PMID: 22416134; PMCID: PMC3346108. Impact Factor (as of 201#): 5.328.*†  Top
  18. Parkin N, de Mendoza C, Schuurman R, Jennings C, Bremer J, Jordan MR, Bertagnolio S; WHO DBS Genotyping Working Group (Yamamura Y). Evaluation of In-house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory Network. Clin Infect Dis. May 2012;54 Suppl 4:S273-S279. doi: 10.1093/cid/cir982. PMID: 22544187; PMCID: PMC3338305. Impact Factor (as of 2010): 8.186.   Top
  19. Perez R, Gibson S, Lopez P, Koenig E, De Castro M, Yamamura Y. Distribution of HIV-1 Infection in Different T Lymphocyte Subsets: Antiretroviral Therapy-Naïve vs. Experienced Patients. AIDS Res Hum Retroviruses. Apr 2011;27(4):399-410. doi: 10.1089/aid.2010.0176. Epub 2010 Nov 7. PMID: 21054214 [PubMed - in process]. Impact Factor (as of 2010): 2.178.    Top
  20. Contreras-Galindo RA, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez M, Ferlengui I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y, Markovitz DM. Characterization of Human Endogenous Retroviral Elements in the Blood of HIV-1-Infected Individuals. J Virol. Oct 26, 2011 [Epub ahead of print]. PMID: 22031938. Impact Factor (as of 2010): 5.189.   Top
  21. Liang Q, Deng H, Li X, Wu X, Tang Q, Chang TH, Peng H, Rauscher FJ 3rd, Ozato K, Zhu F. Tripartite Motif-Containing Protein 28 Is a Small Ubiquitin-Related Modifier E3 Ligase and Negative Regulator of IFN Regulatory Factor 7. J Immunol. Sep 21, 2011. [Epub ahead of print]. PMID: 21940674. Impact Factor (as of 2010): 5.745. No acknowledgement RCMI Grant.   Top
  22. Simmons VN, Quinn G, Litvin EB, Rojas A, Jimenez J, Castro E, Meade CD, Brandon TH. Transcreation of validated smoking relapse-prevention booklets for use with Hispanic populations. J Health Care Poor Underserved. Aug 2011;22(3):886-893. PMID: 21841285. Impact Factor (as of 2009): 0.964. No acknowledgement RCMI Grant.   Top
  23. Chaudhary S, Noel RJ, Rodríguez N, Collado S, Munoz J, Kumar A, Yamamura Y. Correlation between CD4 T cell counts and virus compartmentalization in genital and systemic compartments of HIV-infected females. Virology. Sep 1, 2011;417(2):320-326. Epub 2011 Jul 13. PMID: 21745672 [PubMed - as supplied by publisher]. Impact Factor (as of 2010): 3.305.*   Top
  24. Shah A, Verma AS, Patel KH, Noel R, Rivera-Amill V, Silverstein PS, Chaudhary S, Bhat HK, Stamatatos L, Singh DP, Buch S, Kumar A. HIV-1 gp120 Induces Expression of IL-6 through a Nuclear Factor-Kappa B-Dependent Mechanism: Suppression by gp120 Specific Small Interfering RNA. PLoS One. 2011;6(6):e21261. Epub 2011 Jun 21. PMID: 21712995 [PubMed - in process]. PMCID: PMC3119684. Impact Factor (as of 2009): 4.351. No acknowledgement RCMI Grant.   Top
  25. Cosme-Cruz R, Puerta Martinez F, Perez KJ, Tang Q. H2B Homology Region of Major Immediate-Early (MIE) Protein 1 (IE1) Is Essential for Murine Cytomegalovirus to Disrupt Nuclear Domain 10 (ND10), but Not Important for Viral Replication in Cell Culture. J Gen Virol. Jun 1, 2011. [Epub ahead of print]. PMID: 21632568 [PubMed - as supplied by publisher]. Impact Factor (as of 2009): 3.260.*   Top
  26. Quinn GP, Jimenez J, Meade CD, Muñoz-Antonia T, Gwede CK, Castro E, Vadaparampil ST, Simmons VN, McIntyre J, Crocker TT, Brandon TH. Enhancing oncology health care provider's sensitivity to cultural communication to reduce cancer disparities: a pilot study. J Cancer Educ. Jun 2011;26(2):322-325. PMID: 21479572. Impact Factor (as of 2010): 0.682. No acknowledgement RCMI Grant.   Top
  27. Cosme RC, Martínez FP, Tang Q. Functional Interaction of Nuclear Domain 10 and Its Components with Cytomegalovirus after Infections: Cross-Species Host Cells versus Native Cells. PLoS One. Apr 28, 2011;6(4):e19187. PMID: 21552525 [PubMed - in process]. Impact Factor (as of 2009): 4.351.*   Top
  28. Norman LR, Dévieux JG, Rosenberg R, Malow RM. HIV-Testing Practices and a History of Substance Use among Women Living in Public Housing in Puerto Rico. J Int Assoc Physicians AIDS Care (Chic). Apr 20, 2011. [Epub ahead of print]. PMID: 21508299 [PubMed - as supplied by publisher]. Impact Factor: NA.* No acknowledgement RCMI Grant.   Top
  29. Huang Y, Tang Q, Nguyen M, Dulal K, Wang W, Zhu H. Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus. Virol J. Mar 31, 2011;8(1):151. [Epub ahead of print]. PMID: 21453528 [PubMed - as supplied by publisher]. Impact Factor (as of 2010): 2.440.*   Top
  30. Simmons VN, Jiménez JC, Castro E, Litvin EB, Gwede CK, Vadaparampil ST, Mclntyre J, Meade CD, Brandon TH, Quinn GP. Initial efforts in community engagement with health care providers: perceptions of barriers to care for cancer patients in Puerto Rico. P R Health Sci J. Mar 2011;30(1):28-34. PMID: 21449495. Impact Factor: NA. No acknowledgement RCMI Grant.   Top
  31. Jiménez J, Puig M, Sala A, Ramos J, Castro E, Morales M, Santiago L, Zorrilla C. Felt Stigma in Injection Drug Users and Sex Workers: Focus Group Research with HIV-Risk Populations in Puerto Rico. Qual Res Psychol. 2011;8(1):26-39. PMID: NA. Impact Factor: NA. No PMID #
  32. Litvin EB, Rojas AR, Brandon TH, Meade CD, Quinn G, Jiménez J, Castro E, Diaz Z, Simmons VN. Cultural acceptability of a smoking relapse prevention intervention for pregnant women in Puerto Rico: Providers’ feedback. Hisp Health Care Int. 9(3):117-126. PMID: NA. Impact Factor: NA. No PMID #   Top
Other PSMHS Investigators
  1. Pérez-Mayoral J, Pacheco-Torres AL, Morales L, Acosta-Rodríguez H, Matta JL, Dutil J. Genetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in Puerto Rican women. Mol Carcinog. Jun 18, 2013. doi: 10.1002/mc.22056. [Epub ahead of print]. PMID: 237760894; PMCID: NA. Impact Factor (as of 2012): 4.269.  Top
  2. Bauckman KA, Haller E, Flores I, Nanjundan M. Iron modulates cell survival in a Ras- and MAPK-dependent manner in ovarian cells. Cell Death Dis. Apr 18, 2013;4:e592. doi: 10.1038/cddis.2013.87. PMID: 23598404; PMCID: NA. Impact Factor (as of 2011): 5.333.  Top
  3. Ferder M, Inserra F, Manucha W, Ferder L. The world pandemic of Vitamin D deficit could possibly be explained by cellular inflammatory response activity induced by the renin angiotensin system. Am J Physiol Cell Physiol. Jan 30, 2013. PMID: 23364265; PMCID: NA. Impact Factor (as of 2011): 3.536.*†  Top
  4. Dávila S, Marín R, Fourquet J, Flores I. Modeling the Risk of Endometriosis in Puerto Rican Females. In: Krishnamurthy A, Chan WKV, eds. Proceedings of the 2013 Industrial and Systems Engineering Research Conference. 2013. PMID: NA; PMCID: NA. Impact Factor: NA.  Top
  5. Husain K, Centeno BA, Chen DT, Fulp WJ, Perez M, Zhang Lee G, Luetteke N, Hingorani SR, Sebti SM, Malafa MP. Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E, δ-tocotrienol. Carcinogenesis. Apr 2013;34(4):858-863. doi: 10.1093/carcin/bgt002. Epub 2013 Jan 9. PMID: 22869605; PMCID: PMC3616675. Impact Factor (as of 2011): 5.702.
  6. Vergne Y, Matta JL, Morales L, Vargas W, Álvarez-Garriga C, Bayona M. Breast Cancer and DNA Repair Capacity: Association With Use of Multivitamin and Calcium Supplements. Integr Med (Encinitas). PMID: NA; PMCID: NA. Impact Factor: NA.*†  Top
  7. Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, Schultz M, Davis MN, Kayali Z, Reddy KR, Jacobson IM, Kowdley KV, Nyberg L, Subramanian GM, Hyland RH, Arterburn S, Jiang D, McNally J, Brainard D, Symonds WT, McHutchison JG, Sheikh AM, Younossi Z, Gane EJ. Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection. N Engl J Med. Apr 23, 2013. PMID: 23607594; PMCID: NA. Impact Factor (as of 2011): 53.298.  Top
  8. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR. Treatment of HCV Infection by Targeting MicroRNA. N Engl J Med. May 2, 2013;368(18):1685-1694. doi: 10.1056/NEJMoa1209026. Epub 2013 Mar 27. PMID: 23534542; PMCID: NA. Impact Factor (as of 2011): 53.298.  Top
  9. Lawitz E, Lalezari JP, Hassanein T, Kowdley KV, Poordad FF, Sheikh AM, Afdhal NH, Bernstein DE, Dejesus E, Freilich B, Nelson DR, Dieterich DT, Jacobson IM, Jensen D, Abrams GA, Darling JM, Rodriguez-Torres M, Reddy KR, Sulkowski MS, Bzowej NH, Hyland RH, Mo H, Lin M, Mader M, Hindes R, Albanis E, Symonds WT, Berrey MM, Muir A. Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial. Lancet Infect Dis. May 2013;13(5):401-408. doi: 10.1016/S1473-3099(13)70033-1. Epub 2013 Mar 15. PMID: 23499158; PMCID: NA. Impact Factor (as of 2011): 17.390.  Top
  10. Lawitz E, Rodriguez-Torres M, Stoehr A, Gane EJ, Serfaty L, Bhanja S, Barnard RJ, An D, Gress J, Hwang P, Mobashery N. A Phase 2b Study of Mk-7009 (Vaniprevir) in Patients with Genotype 1 Hcv Infection who have Failed Previous Pegylated Interferon and Ribavirin Treatment. J Hepatol. Feb 21, 2013. pii: S0168-8278(13)00130-X. doi: 10.1016/j.jhep.2013.02.008. PMID: 23439259; PMCID: NA. Impact Factor (as of 2011): 9.264.  Top
  11. Wedemeyer H, Jensen D, Herring R Jr, Ferenci P, Ma MM, Zeuzem S, Rodriguez-Torres M, Bzowej N, Pockros P, Vierling J, Ipe D, Lou Munson M, Chen YC, Najera I, Thommes J; on behalf of the PROPEL Investigators. PROPEL: A randomized trial of mericitabine plus peginterferon alfa-2a/ribavirin therapy in treatment-naive HCV Genotype 1/4 patients. Hepatology. Jan 24, 2013. doi: 10.1002/hep.26274. PMID: 23348636; PMCID: NA. Impact Factor (as of 2011): 11.665.  Top
  12. Antoon JW, Nitzchke AM, Martin EC, Rhodes LV, Nam S, Wadsworth S, Salvo VA, Elliott S, Collins-Burow B, Nephew KP, Burow ME. Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition. Int J Oncol. Apr 2013;42(4):1139-1150. doi: 10.3892/ijo.2013.1814. Epub 2013 Feb 8. PMID: 23403951; PMCID: PMC3622654. Impact Factor (as of 2011): 2.399.  Top
  13. Peru Y Colón de Portugal RL, Acevedo SF, Rodan AR, Chang LY, Eaton BA, Rothenfluh A. Adult Neuronal Arf6 Controls Ethanol-Induced Behavior with Arfaptin Downstream of Rac1 and RhoGAP18B. Dec 5, 2012;32(49):17706-17713. doi: 10.1523/JNEUROSCI.1944-12.2012. PMID: 23223291; PMCID: PMC3535434. Impact Factor (as of 2011): 7.115.  Top
  14. Acevedo SF. Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing? 2012;6:181-190. doi: 10.4137/BCBCR.S10293. Epub Nov 19, 2012. PMID: 23226022; PMCID: PMC3512448. Impact Factor: NA.*†  Top
  15. Tsigkari KK, Acevedo SF, Skoulakis EM. 14-3-3ε Is required for germ cell migration in Drosophila. PLoS One. 2012;7(5):e36702. doi: 10.1371/journal.pone.0036702. Epub 2012 May 30. PMID: 22666326; PMCID: PMC3364263. Impact Factor (as of 2011): 4.092.  Top
  16. Acevedo SF. The Confounding Factor of Apolipoprotein E on Response to Chemotherapy and Hormone Regulation Altering Long-Term Cognition Outcomes. In: Frank S, Kostner G, eds. Lipoproteins - Role in Health and Diseases. Rijeka, Croatia: InTech; 2012. PMID: NA; PMCID: NA. Impact Factor: NA.†  Top
  17. Morales D, Acevedo SF, Skolasky RL, Hechavarria R, Santiago S, De La Torre T, Maldonado E, Wojna V. Acevedo SF, Skolasky RL, Hechavarria R, Santiago S, De La Torre T, Maldonado E, Wojna V. Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women. J Neurovirol Dec 2012;18(6):488-502. doi: 10.1007/s13365-012-0128-8. Epub 2012 Sep 13. PMID: 22972599; PMCID: PMC3508384. Impact Factor (as of 2011): 2.310.*†  Top
  18. Morales D, Skoulakis EC, Acevedo SF. 14-3-3s are potential biomarkers for HIV-related neurodegeneration. J Neurovirol. Oct 2012;18(5):341-353. doi: 10.1007/s13365-012-0121-2. Epub 2012 Jul 19. PMID: 22811265; PMCID: NA. Impact Factor (as of 2011): 2.310.*†  Top
  19.  Baez A, Pacheco W, Appleyard CB. The graduate student portfolio: organize and energize your career development. Physiologist. Oct 2012;55(5):177-178. PMID: 23155926; PMCID: NA. Impact Factor: NA.  Top
  20. Colón-Días M, Báez-Vega P, García M, Ruiz A, Monteiro JB, Fourquet J, Bayona M, Alvarez-Garriga C, Achille A, Seto E, Flores I. HDAC1 and HDAC2 are Differentially Expressed in Endometriosis. Reprod Sci. May 2012;19(5):483-492. Epub 2012 Feb 16. PMID: 22344732; PMCID: PMC3343094. Impact Factor (as of 2010): 2.586.  Top
  21. Collazo MS, Porrata-Doria T, Flores I, Acevedo SF. Apolipoprotein E Polymorphisms and Spontaneous Pregnancy Loss in Patients with Endometriosis. Mol Hum Reprod. Jul;18(7):372-377. doi: 10.1093/molehr/gas004. Epub 2012 Jan 20. Epub 2012 Feb 3. PMID: 22266326; PMCID: PMC3378305. Impact Factor (as of 2010): 3.506.*†  Top
  22. Suárez E, González L, Soto-Salgado M, Bayona M. Report of the 2011 University of Puerto Rico-MD Anderson Cancer Center conference entitled “Population-Based Studies in Hispanics: Methodological Issues in Cancer Research”. P R Health Sci J. Mar 2012;31(1):39-41. NA; PMID: 22432409; PMCID: NA. Impact Factor: NA.*†  Top
  23. García IM, Altamirano L, Mazzei LJ, Fornes MW, Molina MN, Ferder L, Manucha W. Role of Mitochondria in Paricalcitol-mediated Cytoprotection During Obstructive Nephropathy. Am J Physiol Renal Physiol. Jun 15, 2012;302(12):F1595-605. Epub 2012 Apr 4. PMID: 22492946; PMCID: NA. Impact Factor (as of 2010): 3.792.*†  Top
  24. Grechukhina O, Petracco R, Popkhadze S, Massasa E, Paranjape T, Chan E, Flores I, Weidhaas JB, Taylor HS. A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis. EMBO Mol Med. Mar 2012;4(3):206-217. doi: 10.1002/emmm.201100200. Epub 2012 Feb 3. PMID: 22473713; PMCID: PMC3376847. Impact Factor (as of 2010): 10.885.  Top
  25. Ansari RA, Rizvi SA, Husain K, Lymperopoulos A, Berndt WO. Effect of sulfhydryl modification on rat kidney basolateral plasma membrane transport function. Bull Environ Contam Toxicol. Oct 2012;89(4):699-703. doi: 10.1007/s00128-012-0756-y. Epub 2012 Aug 2. PMID: 22936015; PMCID: NA. Impact Factor (as of 2011): 1.018.  Top
  26. Lawitz E, Rodriguez-Torres M, Denning JM, Albanis E, Cornpropst M, Berrey MM, Symonds WT. Pharmacokinetics, pharmacodynamics, and tolerability of GS-9851, a nucleotide analog polymerase inhibitor, following multiple ascending doses in patients with chronic hepatitis C infection. Antimicrob Agents Chemother. Mar 2013;57(3):1209-1217. doi: 10.1128/AAC.01263-12. Epub 2012 Dec 21. PMID: 23263000; PMCID: PMC3591915. Impact Factor (as of 2011): 4.841.  Top
  27. Rodriguez-Torres M. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient. Curr Opin Infect Dis. Feb 2013;26(1):50-7. doi: 10.1097/QCO.0b013e32835c2027. PMID: 23242341; PMCID: NA. Impact Factor (as of 2011): 4.930.  Top
  28. Ogura N, Toyonaga Y, Ando I, Hirahara K, Shibata T, Turcanu G, Pai S, Yee K, Gerhardt B, Rodriguez-Torres M, Noguchi T. Genotypic and Phenotypic Analyses of Hepatitis C Virus from Patients Treated with JTK-853 in a 3-Day Monotherapy. Antimicrob Agents Chemother. Jan 2013;57(1):436-444. doi: 10.1128/AAC.01432-12. Epub 2012 Nov 5. PMID: 22936015; PMCID: PMC3535980. Impact Factor (as of 2011): 4.841.  Top
  29. Rodriguez-Torres M, Lawitz E, Kowdley KV, Nelson DR, Dejesus E, McHutchison JG, Cornpropst MT, Mader M, Albanis E, Jiang D, Hebner CM, Symonds WT, Berrey MM, Lalezari J. Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial. J Hepatol. Nov 23, 2012. pii: S0168-8278(12)00887-2. doi: 10.1016/j.jhep.2012.11.018. PMID: 23183528; PMCID: NA. Impact Factor (as of 2011): 9.264.  Top
  30. Zeuzem S, Rodríguez-Torres M, Rajender Reddy K, Marcellin P, Diago M, Craxi A, Pockros P, Rizzetto M, Bernstein D, Shiffman ML, Lin A, Tatsch F, Hadziyannis S. Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin. J Viral Hepat. Nov 2012;19(11):766-774. doi: 10.1111/j.1365-2893.2012.01624.x. Epub 2012 May 14. PMID: 23043383; PMCID: NA. Impact Factor (as of 2011): 4.088.  Top
  31. Lawitz EJ, Hill JM, Marbury T, Demicco MP, Delaney W, Yang J, Moorehead L, Mathias A, Mo H, McHutchison JG, Rodriguez-Torres M, Gordon SC. A Phase 1, randomized, placebo-controlled, three-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients. Antivir Ther. Oct 9, 2012. doi: 10.3851/IMP2415. PMID: 23047118; PMCID: NA. Impact Factor (as of 2011): 3.283.  Top
  32. Rodríguez-Torres M. Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient. Expert Rev Anti Infect Ther. Oct 201;10(10):1117-1128. doi: 10.1586/eri.12.107. PMID: 23199398; PMCID: NA. Impact Factor (as of 2011): 3.16.  Top
  33. Szabo SM, Bibby M, Yuan Y, Donato BM, Jiménez-Mendez R, Castañeda-Hernández G, Rodríguez-Torres M, Levy AR. The epidemiologic burden of hepatitis C virus infection in Latin America. Ann Hepatol. Sep 2012;11(5):623-635. PMID: 22947522; PMCID: NA. Impact Factor (as of 2011): 1.811.  Top
  34. Harrison SA, Abdurakhmanov D, Shiffman ML, Bakulin I, Mazur W, Rodríguez-Torres M, Silva GF, Cheinquer H, Messinger D, Connell EV, McKenna M, Tatsch F, Reddy KR; on behalf of the PROGRESS Investigators. Intensified Peginterferon α-2a Dosing Increases Sustained Virologic Response Rates in Heavy, High Viral Load Hepatitis C Genotype 1 Patients With High Low-density Lipoprotein. J Clin Gastroenterol. Mar;47(3):271-9. doi: 10.1097/MCG.0b013e31826102eb. Epub 2012 Aug 30. PMID: 22951527; PMCID: NA. Impact Factor (as of 2010): 3.159.  Top
  35. Rodríguez-Torres M, Burguera J, Hallman D, Rodríguez-Orengo J, Echeandia M. Hepatitis C viral kinetics in Latino patients: a comparison to African American and Caucasian patients. Ann Hepatol. Jul 2012;11(4):450-463. PMID: 22700626; PMCID: NA. Impact Factor (as of 2011): 1.811.  Top
  36.  Marcellin P, Cheinquer H, Curescu M, Dusheiko GM, Ferenci P, Horban A, Jensen D, Lengyel G, Mangia A, Ouzan D, Puoti M, Rodriguez-Torres M, Shiffman ML, Schmitz M, Tatsch F, Rizzetto M. High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials. Hepatology. Dec 2012;56(6):2039-2050. doi: 10.1002/hep.25892. Epub 2012 Aug 8. PMID: 22706730; PMCID: NA. Impact Factor (as of 2011): 11.665.  Top
  37. Rodriguez-Torres M, Slim J, Bhatti L, Sterling R, Sulkowski M, Hassanein T, Serrão R, Sola R, Bertasso A, Passe And S, Stancic S. Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial. HIV Clin Trials. May-Jun, 2012;13(3):142-
    152. PMID: 22592094; PMCID: NA. Impact Factor (as of 2012): 1.835.  Top
  38. Manns MP, Gane E, Rodriguez-Torres M, Stoehr A, Yeh CT, Marcellin P, Wiedmann RT, Hwang PM, Caro L, Barnard RJ, Lee AW; for the MK-7009 Protocol 007 Study Group. Vaniprevir with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: a randomized phase II study. Hepatology. Sep 2012;56(3):884-893. doi: 10.1002/hep.25743. Epub 2012 Jul 17. PMID: 22473713; PMCID: NA. Impact Factor (as of 2011): 11.665.  Top
  39. Opravil M, Rodriguez-Torres M, Rockstroh J, Snoeck E, Chung RT, Tietz A, Torriani FJ. The Dose-Response Relationship of Peginterferon Alfa-2a and Ribavirin in the Treatment of Patients Coinfected with HIV-HCV. HIV Clin Trials. Jan-Feb 2012;13(1):33-45. PMID: 22306586; PMCID: NA. Impact Factor (as of 2012): 1.835.  Top
  40. Pasquinelli C, McPhee F, Eley T, Villegas C, Sandy K, Sheridan P, Persson A, Huang SP, Hernandez D, Sheaffer AK, Scola P, Marbury T, Lawitz E, Goldwater R, Rodriguez-Torres M, Demicco M, Wright D, Charlton M, Kraft WK, Lopez-Talavera JC, Grasela DM. Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C. Antimicrob Agents Chemother. Apr 2012;56(4):1838-1844. doi: 10.1128/AAC.05854-11. Epub 2012 Jan 30. PMID: 22290978; PMCID: PMC3318341. Impact Factor (as of 2011): 4.841.  Top
  41. Nelson DR, Zeuzem S, Andreone P, Ferenci P, Herring R, Jensen DM, Marcellin P, Pockros PJ, Rodríguez-Torres M, Rossaro L, Rustgi VK, Sepe T, Sulkowski M, Thomason IR, Yoshida EM, Chan A, Hill G. Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients. Ann Hepatol. Jan 2012;11(1):15-31. PMID: 22166557; PMCID: NA. Impact Factor (as of 2011): 1.811.  Top
  42. Antoon JW, Bratton MR, Guillot LM, Wadsworth S, Salvo VA, Elliott S, McLachlan JA, Burow ME. Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase. Am J Cancer Res. 2012;2(4):446-458. Epub 2012 Jun 28. PMID: 22860234; PMCID: PMC3410584. Impact Factor: NA.
  43. Antoon JW, Bratton MR, Guillot LM, Wadsworth S, Salvo VA, Burow ME. Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation. Cancer Biol Ther. Sep 2012;13(11):1026-1033. doi: 10.4161/cbt.20992. Epub 2012 Jul 24. PMID: 22290978; PMCID: PMC3461809. Impact Factor (as of 2011): 2.636.  Top
  44. Antoon JW, Lai R, Struckhoff AP, Nitschke AM, Elliott S, Martin EC, Rhodes LV, Yoon NS, Salvo VA, Shan B, Beckman BS, Nephew KP, Burow ME. Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance. Sci Rep. 2012;2:539. Epub 2012 Jul 27. PMID: 22844580; PMCID: PMC3406343. Impact Factor: NA.  Top
  45. Ramirez N, Flynn JM, Casalduc F, Rodriguez S, Cornier AS, Carlo S. Musculoskeletal manifestations of neonatal nonketotic hyperglycinemia. J Child Orthop. Jul, 2012;6(3):199-203. doi: 10.1007/s11832-012-0407-1. Epub 2012 May 25. PMID: 23814620; PMCID: PMC3400000. Impact Factor: NA.  Top
  46. Varas-Díaz N, Neilands TB, Cintrón-Bou F, Santos-Figueroa A, Rodríguez-Madera S, Santiago-Negrón S. The role of gender on HIV/AIDS stigma among medical students in Puerto Rico: implications for training and service delivery. P R Health Sci J. Dec 2012;31(4):220-222. PMID: 23844470; PMCID: PMC3400000. Impact Factor: NA.  Top
  47. Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield JL, Ramachandran A, Riddle MC, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein HC; TIDE Trial Investigators (Tirado G). Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia. Jan 2012;55(1):36-45. Epub 2011 Oct 29. PMID: 22038523; PMCID: NA. Impact Factor (as of 2011): 6.814.  Top
  48. Zavala-Zegarra DE, López-Charneco M, Garcia-Rivera EJ, Concha-Eastman A, Rodriguez JF, Conte-Miller M. Geographic distribution of risk of death due to homicide in Puerto Rico, 2001-2010. Rev Panam Salud Publica. Nov 2012;32(5):321-329. PMID: 23338688; PMCID: NA. Impact Factor (as of 2010): 0.706.  Top
  49. Pagán B, Isidro AA, Cruz ML, Ren Y, Coppola D, Wu J, Appleyard CB. Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model. World J Gastroenterol. Nov 14, 2011; 17(42):??-??. PMID: Pending. Impact Factor (as of 2009): 2.092.   Top
  50. Castro MD, Suarez E, Kraiselburd E, Isidro A, Paz J, Ferder L, Ayala-Torres S. Aging increases mitochondrial DNA damage and oxidative stress in liver of rhesus monkeys. Exp Gerontol. Oct 12, 2011. [Epub ahead of print]. PMID: 22027539. Impact Factor (as of 2010): 3.804. No acknowledgement RCMI Grant.   Top
  51. Husain K, Francois RA, Yamauchi T, Perez M, Sebti SM, Malafa MP. Vitamin E {delta}-Tocotrienol Augments the Anti-tumor Activity of Gemcitabine and Suppresses Constitutive NF-{kappa}B Activation in Pancreatic Cancer. Mol Cancer Ther. Oct 4, 2011. [Epub ahead of print]. PMID: 21971120. Impact Factor (as of 2010): 5.225. No acknowledgement RCMI Grant.  Top
  52. Finch JL, Suarez EB, Husain K, Ferder L, Cardema MC, Glenn DJ, Gardner DG, Liapis H, Slatopolsky E. The Effect of Combining an ACE Inhibitor and a VDR Activator on Glomerulosclerosis, Proteinuria and Renal Oxidative Stress in Uremic Rats. Am J Physiol Renal Physiol. 2011 Sep 28. [Epub ahead of print]. PMID: 21957179. Impact Factor (as of 2010): 3.79. No acknowledgement RCMI Grant.   Top
  53. Rasmussen A, Sevier S, Kelly JA, Glenn SB, Aberle T, Cooney CM, Grether A, James E, Ning J, Tesiram J, Morrisey J, Powe T, Drexel M, Daniel W, Namjou B, Ojwang JO, Nguyen KL, Cavett JW, Te JL, James JA, Scofield RH, Moser K, Gilkeson GS, Kamen DL, Carson CW, Quintero-del-Rio AI, del Carmen Ballesteros M, Punaro MG, Karp DR, Wallace DJ, Weisman M, Merrill JT, Rivera R, Petri MA, Albert DA, Espinoza LR, Utset TO, Shaver TS, Arthur E, Anaya JM, Bruner GR, Harley JB. The Lupus Family Registry and Repository. Rheumatology (Oxford). Jan 2011;50(1):47-59. Epub 2010 Sep 23. PMID: 20864496. Impact Factor (as of 2010): 4.171.   Top
  54. Appleyard CB, Cruz ML, Isidro AA, Arthur JC, Jobin C, De Simone C. Pretreatment with the Probiotic VSL#3 Delays Transition from Inflammation to Dysplasia in a Rat Model of Colitis-associated Cancer. Am J Physiol Gastrointest Liver Physiol. Sep 8, 2011. [Epub ahead of print]. PMID: 21903764 [PubMed]. Impact Factor (as of 2010): 3.522.* No acknowledgement RCMI Grant.   Top
  55. Rhodes LV, Bratton MR, Zhu Y, Tilghman SL, Muir SE, Salvo VA, Tate CR, Elliott S, Nephew KP, Collins-Burow BM, Burow ME. Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells. Exp Cell Res. Aug 30, 2011. [Epub ahead of print]. PMID: 21906588. Impact Factor (as of 2011): 3.609.   Top
  56. Thompson AJ, Patel K, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Rustgi VK, Flisiak R, Pianko S, Diago M, Arora S, Foster GR, Torbenson M, Benhamou Y, Nelson DR, Sulkowski MS, Zeuzem S, Pulkstenis E, Subramanian GM, McHutchison JG; for the ACHIEVE-1 and ACHIEVE-2/3 Study Teams. Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Gut. Aug
    26, 2011. [Epub ahead of print]. PMID: 21873466. Impact Factor (as of 2010): 10.614. No acknowledgement RCMI Grant.   Top
  57. August EM, Quinn GP, Perales R, Closser Z, Dutil J, Puig M, Vadaparampil ST. Important Considerations for Recruiting Women to Cancer Genetics Studies in Puerto Rico. J Cancer Educ. Aug 25, 2011. [Epub ahead of print]. PMID: 21866412. Impact Factor (as of 2010): 0.682. No acknowledgement RCMI Grant.   Top
  58. Vera J, Gao LM, Santana A, Matta J, Meléndez E. Vectorized ferrocenes with estrogens and vitamin D(2): synthesis, cytotoxic activity and docking studies. Dalton Trans. 2011 Aug 18. [Epub ahead of print]. PMID: 21850331 [PubMed - as supplied by publisher]. Impact Factor (as of 2010): 4.08. No acknowledgement RCMI Grant.   Top
  59. Nettles RE, Gao M, Bifano M, Chung E, Persson A, Marbury TC, Goldwater R, Demicco MP, Rodriguez-Torres M, Vutikullird A, Fuentes E, Lawitz E, Carlos Lopez-Talavera J, Grasela DM. Multiple ascending dose study of BMS-790052, an NS5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1. Hepatology. Aug 11, 2011. doi: 10.1002/hep.24609. [Epub ahead of print]. PMID: 21837752 [PubMed - as supplied by publisher]. Impact Factor (as of 2010): 10.885. No acknowledgement RCMI Grant.   Top
  60. Lopez-Charneco M, Conte-Miller MS, Davila-Toro F, García-Rivera EJ, Zavala DE, Torres Y, Rodriguez Orengo JF. Motor Vehicle Accident Fatalities Trends, Puerto Rico 2000-2007. J Forensic Sci. Aug 9, 2011. doi: 10.1111/j.1556-4029.2011.01878.x. [Epub ahead of print]. Impact Factor (as of 2010): PMID: 21827468 1.159.   Top
  61. Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG; BEACON Study Investigators (Barranco E). Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med. Jul 28, 2011;365(4):327-336. Epub 2011 Jun 24. PMID: 21699484. Impact Factor (as of 2010): 53.48. No acknowledgement RCMI Grant.   Top
  62. Vadaparampil ST, Quinn GP, Dutil J, Puig M, Malo T, McIntyre J, Perales R, August EM, Closser Z. A pilot study of knowledge and interest of genetic counseling and testing for hereditary breast and ovarian cancer syndrome among Puerto Rican women. J Community Genet. Jul 12, 2011. [Epub ahead of print]. Impact Factor: NA. No PMID #   Top
  63. Piper BJ, Acevedo SF, Edwards KR, Curtiss AB, McGinnis GJ, Raber J. Age, sex, and handedness differentially contribute to neurospatial function on the Memory Island and Novel-Image Novel-Location tests. Physiol Behav. Jul 6, 2011;103(5):513-522. Epub 2011 Apr 2. PMID: 21463643 [PubMed - as supplied by publisher]. Impact Factor (as of 2010): 3.295. No acknowledgement RCMI Grant.   Top
  64. Ruiz LA, Dutil J, Ruiz A, Fourquet J, Abac S, Laboy J, Flores I. Single-nucleotide polymorphisms in the lysyl oxidase-like protein 4 and complement component 3 genes are associated with increased risk for endometriosis and endometriosis-associated infertility. Fertil Steril. Aug 2011;96(2):512-515. Epub 2011 Jul 5. [Epub ahead of print]. PMID: 21733505 [PubMed - as supplied by publisher]. Impact Factor (as of 2010): 3.122. No acknowledgement RCMI Grant.   Top
  65. Kao WH, Riker AI, Kushwaha DS, Ng K, Enkemann SA, Jove R, Buettner R, Zinn PO, Sánchez NP, Villa JL, D’Andrea AD, Sánchez JL, Kennedy RD, Chen CC, Matta JL. Upregulation of Fanconi Anemia DNA Repair Genes in Melanoma Compared to Non-Melanoma Skin Cancer. J Invest Dermatol. Jun 23, 2011. doi: 10.1038/jid.2011.181. Impact Factor (as of 2009): PMID: 21697891 [PubMed - indexed for MEDLINE] PMCID: PMC3174338 [Available on 2012/4/1] 5.543.*   Top
  66. Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, Handsaker RE, Lunter G, Marth GT, Sherry ST, McVean G, Durbin R; 1000 Genomes Project Analysis Group (Dutil J). The variant call format and VCFtools. Bioinformatics. Aug 1, 2011;27(15):2156-3158. Epub 2011 Jun 7. PMID: 21653522. [PubMed - indexed for MEDLINE]. PMCID: PMC3137218. Impact Factor (as of 2010): 4.877. No acknowledgement RCMI Grant.   Top
  67. Ayala-Feliciano M, Pons-Valerio JJ, Pons-Madera J, Acevedo SF. The Relationship between Visuospatial Memory and Coping Strategies in Breast Cancer Survivors. Breast Cancer (Auckl). 2011;5:117-130. Epub 2011 Jun 1. Impact Factor: NA.* No PMID #   Top
  68. Acevedo SF, Raber J. Histamine-dependent behavioral response to methamphetamine in 12-month-old male mice. Brain Res. Jun 1, 2011;1393:23-30. Epub 2011 Apr 3. PMID: 21466792 [PubMed - as supplied by publisher]. Impact Factor (as of 2010): 2.463.No acknowledgement RCMI Grant.   Top
  69. Fourquet J, Báez L, Figueroa M, Iriarte RI, Flores I. Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril. Jul 2011;96(1):107-12. Epub 2011 May 31. [Epub ahead of print]. PMID: 21621771 [PubMed - as supplied by publisher]. Impact Factor (as of 2010): 3.122. No acknowledgement RCMI Grant.   Top
  70. Smith WR, Ballas SK, McCarthy WF, Bauserman RL, Swerdlow PS, Steinberg MH, Waclawiw MA, Tirado, G (Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia). The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients. Pain Med. May 2011;12(5):697-705. doi: 10.1111/j.1526-4637.2011.01096.x. Epub 2011 Apr 11. PMID: 21481164 [PubMed - in process]. Impact Factor (as of 2010): 2.537. No acknowledgement RCMI Grant.   Top
  71. Acevedo-Acevedo D, Matta J, Meléndez E. Synthesis, characterization and cytotoxic studies of water soluble [(η-C(5)H(5))(2)Mo(thionucleobase/ thionucleoside)]Cl complexes in breast and colon cancer cell lines. J Organomet Chem. Mar 1, 2011;696(5):1032-1037. PMID: 21399723 [PubMed] PMCID: PMC3051372 [Available on 2012/3/1]. Impact Factor (as of 2010): 2.347. No acknowledgement RCMI Grant.   Top
  72. Piper BJ, Acevedo SF, Kolchugina GK, Butler RW, Corbett SM, Honeycutt EB, Craytor MJ, Raber J. Abnormalities in Parentally Rated Executive Function in Methamphetamine/Polysubstance Exposed Children. Pharmacol Biochem Behav. May 2011;98(3):432-9. Epub 2011 Feb 18. PMID: 21334365 [PubMed - as supplied by publisher]. Impact Factor (as of 2009): 2.967.*   Top
  73. Matta JL, Rodriguez G, Villa J, Ruiz A. The role of DNA repair capacity in melanoma skin cancer risk in a population chronically exposed to high levels of sunlight. Ochsner J. Summer 2010;10(2):75-82. PMID: 21603361 [PubMed - in process] PMCID: PMC3096198. Impact Factor: NA.*   Top